Infection Control Market Size, Share & Trends Analysis Report By Type (Equipment, Disinfectors, Sterilization Equipment, Services, Consumables), By End Use, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global infection control market size was estimated at USD 201.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030. The market is predominantly driven by growing number of surgical procedures that require high-intensity infection prevention. The high preference is presumed to be a consequence of positive clinical outcomes associated with usage of infection control. The covid-19 pandemic has positively impacted market growth as the demand for sterilization and disinfection in hospitals and clinics, pharmaceutical, and medical device companies has increased.

For instance, the manufacturing of sanitizer products witnessed rise of 60% during the pandemic in the U.S. alone. This shows the growth potential for infection control products in the coming years. An increase in outsourcing of sterilization services and the introduction of advanced sterilizing solutions are further contributing towards the growth of the market for infection control. The rising number of government initiatives to ensure a high degree infection prevention is presumed to be a significant growth driver.

Government organizations are increasingly involved in issuing guidelines in order to promote awareness pertaining to efficient prevention measures globally, which is expected to contribute to market growth throughout the forecast period. For instance, the World Health Organization (WHO) has issued guidelines for the prevention and control of pandemic- and epidemic-prone acute respiratory diseases in healthcare. The guidelines range from standard precautions such as hand hygiene, usage of personal protective equipment, to guidelines for disinfection, and sterilization.

According to the statistics published by WHO, Acute Respiratory Diseases (ARDs) is one of the major causes of high mortality rates globally. Approximately 4.0 million deaths occur every year due to ARDs. The aforementioned statistics exemplify the high need for stringent prevention and control. Diseases such as pneumonia and infections such as bloodstream, urinary tract, surgical site, MRSA constitute majority of the overall hospital-acquired infections. Other major Hospital-acquired Infections (HAI) include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstreams. HAI is believed to be one of the major concerns, that affects patient recovery, thereby, creating a major impact on mortality rates globally.

According to a practical guide published by the WHO on the prevention of HAI, the increase in hospitalization duration with surgical infections was found to be approximately 8 days. These prolonged stays are predicted to be a significant contributor to the overall costs, incurred during the hospitalization period, thus, raising the clinical urgency for adoption of infection prevention measures. It is presumed that prolonged hospital stay is also not economical for the hospitals and healthcare payers as a consequence of excessive usage of resources to treat the acquired infection. These additional costs are majorly generated through increased usage of drugs, additional diagnostic studies, laboratory equipment, creating a resource allocation imbalance.

Type Insights

The consumables segment dominated the market for infection control and accounted for the largest revenue share of 76.5% in 2021. The dominant share captured by consumables is predicted to be a consequence of consistent usage and the short life cycle possessed by these products. Consumables are being extensively incorporated in disinfection, sterilization and other control procedures and are indispensable part of the aforementioned procedures, thereby, accounting for a larger share. Under consumables, personal protective equipment held a substantial share as of 2021. Various healthcare organizations are advocating and promoting awareness pertaining to the benefits of personal protective equipment, which is anticipated to be responsible for a significant share.

These organizations also strive to promote the adoption through issuing guidelines and recommendations for selection, risk assessment, rational usage, removal, considerations to reduce the risk of transmission of respiratory pathogens to healthcare workers and other medical staff within a healthcare facility. In the type segment, services are expected to grow at a lucrative rate throughout the forecast period. This fastest growth is attributed to the high inclination of market players to reduce overall healthcare expenditure along with utilization of benefits involved. It primarily includes cost advantages, increased efficiency of services, enhanced productivity, and a significantly higher focus on the core areas of development, which are highly critical to a company’s overall profit and growth.

End-use Insights

The hospitals segment dominated the market for infection control and accounted for the largest revenue share of 39.5%  in 2021 and is anticipated to attain the fastest CAGR throughout the forecast period. The substantial share is majorly a consequence of high probability of acquiring infections in hospital premises through respiratory or bloodborne pathogen transmission. HAIs are one of the major challenges and thus require stringent control. This has urged hospitals and public health organizations to adopt highly efficient control systems. Also, as per research published in NCBI, 40% to 60% of hospital infections were estimated to be of surgical sites.

High risk of infection from bloodborne pathogens, drug-resistant pathogens, and others in the operating room is one of the major concerns. For instance, frequent usage of urinary catheters poses a high risk of UTIs and may result in catheter-associated (CA)-UTIs. According to research published in NCBI, UTIs account for 25% of all bacterial infections. As per the data published in the National Nosocomial Infection Surveillance (NNIS) system report, most hospital-acquired UTIs are associated with catheterization and CA-bacteriuria is the most frequently occurring HAI globally, accounting for up to 40% of HAIs in the U.S. each year. These factors are expected to widen the future growth prospects of the market.

Regional Insights

North America dominated the infection control market and accounted for the largest revenue share of 33.9% in 2021. A consistent number of strategic collaborations adopted by key market players to widen their product portfolio and infection control capabilities are believed to be responsible for the greater share captured by this region. In addition, increasing efforts by the established companies to widen their presence across this region is responsible for the dominant share of captured by North America. For instance, In January 2017, Advanced Sterilization Products launched the STERRAD 100NX System with ALLClear in the U.S. and is planning to expand its footprint into regions such as Europe, Africa, and Middle East.

In Asia Pacific, the market for infection control is expected to exhibit the fastest CAGR throughout the forecast period owing to the growing presence of outsourcing organizations, growing healthcare expenditure, and unprecedented evolution of the healthcare standards and infrastructure across this region. The presence of various voluntary and government organizations focused on improving infection control standards is also one of the significant factors contributing to the growth of the Asia Pacific region. Increasing trend of outsourcing by established market players in developed economies, to companies in Asia Pacific region, also serves as key growth impelling factor for the market. For instance, the Asia Pacific Society of Infection Control (APSIC) is a voluntary organization working in the direction of establishing collaborative partnerships to facilitate quality improvement and conduct infection control research to promote cost-efficient practices throughout the Asia Pacific region.

Key Companies & Share Insights

The competition is marked by extensive implementation of collaborative strategies by major companies such as Advanced Sterilization Products, STERUS Corporation, Cantel Medical Corporation, which accounts for their dominant market share. These players are highly focused on adopting competitive strategies such as mergers and acquisitions, new product development initiatives, and geographical expansion. For instance, in March 2017, 3M and Kimberly-Clark Health Care signed an alliance to co-develop and deliver surgical and infection prevention solutions utilizing their respective expertise. Similarly, 3M launched a four-hour rapid readout biological indicator for vaporized hydrogen peroxide sterilization, designed to give results in 4 hours and monitored steam sterilization loads. The product was launched to expand the company’s product portfolio. Some of the prominent players in the infection control market include:

• 3M Company

• Belimed AG

• Halyard Health, Inc.

• Getinge Group

• Advanced Sterilization Products

• Matchana Group

• Sterigenics International

• MMM Group

• Cantel Medical Corporation

• STERIS Corporation

 Infection Control Market Report Scope 

Segments Covered in the Report  

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global infection control market report on the basis of  type, end use, and region:

• Type Outlook (Revenue, USD Billion, 2017 - 2030)

  • Equipment

    • Disinfectors

      • Washers

      • Flushes

      • Endoscope Reprocessors

    • Sterilization Equipment

      • Heat Sterilization Equipment

      • Low Temperature Sterilization Equipment

      • Radiation Sterilization Equipment

      • Filtration Sterilization Equipment

      • Liquid Sterilization Equipment

    • Others

  • Services

    • Contract Sterilization

      • Ethylene Oxide Sterilization

      • E-beam Sterilization

      • Gamma Sterilization

      • Others

    • Infectious Waste Disposal

  • Consumables

    • Infectious Waste Disposal

    • Disinfectants

    • Sterilization Consumables

    • Personal Protective Equipment

    • Others

• End-use Outlook (Revenue, USD Billion, 2017 - 2030)

  • Hospitals

  • Medical Device Companies

  • Clinical Laboratories

  • Pharmaceutical Laboratories

  • Others

• Regional Outlook (Revenue, USD Billion, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

    • Saudi Arabia